{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:53:49Z","timestamp":1791064429533,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010230","name":"Queensland Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.vhri.2026.102124","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:21:31Z","timestamp":1790018491000},"page":"102124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mapping Healthy Days Scores to EQ-5D-5L Utilities: Development and Validation of an Algorithm Using Population Survey Data"],"prefix":"10.1016","volume":"58","author":[{"given":"Nirmali","family":"Sivapragasam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Senanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeewa","family":"Kularatna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2026.102124_bib1","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","author":"Brazier","year":"2016"},{"key":"10.1016\/j.vhri.2026.102124_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.publhealth.21.1.587","article-title":"Preference-based measures in economic evaluation in health care","volume":"21","author":"Neumann","year":"2000","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"10.1016\/j.vhri.2026.102124_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/obr.12334","article-title":"Predicting adult obesity from childhood obesity: a systematic review and meta-analysis","volume":"17","author":"Simmonds","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.vhri.2026.102124_bib4","article-title":"BMI and all cause mortality: systematic review and non-linear dose\u2014response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants","volume":"353","author":"Aune","year":"2016","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.vhri.2026.102124_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1467-789x.2001.00032.x","article-title":"Obesity and health-related quality of life","volume":"2","author":"Fontaine","year":"2001","journal-title":"Obes Rev"},{"key":"10.1016\/j.vhri.2026.102124_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7525-1-37","article-title":"The Centers for Disease Control and Prevention\u2019s Healthy Days Measures\u2014population tracking of perceived physical and mental health over time","volume":"1","author":"Moriarty","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/pop.2015.0162","article-title":"Leveraging health-related quality of life in population health management: the case for healthy days","volume":"20","author":"Slabaugh","year":"2017","journal-title":"Popul Health Manag"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12955-020-01560-4","article-title":"A comparison of the four healthy days measures (HRQOL-4) with a single measure of self-rated general health in a population-based health survey in New York City","volume":"18","author":"Dumas","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10.1016\/j.vhri.2026.102124_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40258-019-00467-6","article-title":"An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values","volume":"17","author":"Mukuria","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"10.1016\/j.vhri.2026.102124_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.vhri.2026.102124_bib11","series-title":"Guide to the Methods of Technology Appraisal","year":"2013"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jval.2012.10.010","article-title":"Mapping to obtain EQ-5D utility values for use in NICE health technology assessments","volume":"16","author":"Longworth","year":"2013","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s41687-022-00474-7","article-title":"Comparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health","volume":"6","author":"Derkach","year":"2022","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0272989X10364845","article-title":"Predicting the EuroQol group's EQ-5D index from CDC's \u201cHealthy Days\u201d in a US sample","volume":"31","author":"Jia","year":"2011","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1016\/j.vhri.2026.102124_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/0272989X07312708","article-title":"Estimating EuroQol EQ-5D scores from Population Healthy Days data","volume":"28","author":"Jia","year":"2008","journal-title":"Med Decis Mak"},{"issue":"6","key":"10.1016\/j.vhri.2026.102124_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40273-018-0642-5","article-title":"A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D","volume":"36","author":"Buchholz","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.vhri.2026.102124_bib17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","article-title":"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets","volume":"15","author":"van Hout","year":"2012","journal-title":"Value Health"},{"issue":"10","key":"10.1016\/j.vhri.2026.102124_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40273-015-0312-9","article-title":"The MAPS Reporting statement for studies mapping onto generic preference-based outcome measures: explanation and elaboration","volume":"33","author":"Petrou","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jval.2016.11.006","article-title":"Mapping to estimate health-state utility from non-preference-based outcome measures: an ISPOR good practices for outcomes research task force report","volume":"20","author":"Wailoo","year":"2017","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vhri.2026.102124_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jval.2024.02.007","article-title":"EQ-5D-5L population norms and quality-adjusted life expectancy by sociodemographic characteristics and modifiable risk factors for adults in Queensland, Australia","volume":"27","author":"Endo","year":"2024","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2026.102124_bib21","series-title":"Australian Statistical Geography Standard (ASGS)","year":"2025"},{"issue":"4","key":"10.1016\/j.vhri.2026.102124_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40273-023-01243-0","article-title":"The use of a discrete choice experiment including both duration and dead for the development of an EQ-5D-5L value set for Australia","volume":"41","author":"Norman","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.vhri.2026.102124_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/0272989X13500720","article-title":"A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes","volume":"34","author":"Hern\u00e1ndez Alava","year":"2014","journal-title":"Med Decis Making"},{"issue":"6","key":"10.1016\/j.vhri.2026.102124_bib24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.csda.2011.10.005","article-title":"A general class of zero-or-one inflated beta regression models","volume":"56","author":"Ospina","year":"2012","journal-title":"Comput Stat Data Anal"},{"issue":"402","key":"10.1016\/j.vhri.2026.102124_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/01621459.1988.10478611","article-title":"High breakdown-point estimates of regression by means of the minimization of an efficient scale","volume":"83","author":"Yohai","year":"1988","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"10.1016\/j.vhri.2026.102124_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1524-4733.2002.54128.x","article-title":"A comparison of methods for analyzing health-related quality-of-life measures","volume":"5","author":"Austin","year":"2002","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.vhri.2026.102124_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/0266476042000214501","article-title":"Beta regression for modelling rates and proportions","volume":"31","author":"Ferrari","year":"2004","journal-title":"J Appl Stat"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12955-020-01435-8","article-title":"Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis","volume":"18","author":"Mart\u00edn-Fern\u00e1ndez","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1198\/0003130042836","article-title":"A tutorial on MM algorithms","volume":"58","author":"Hunter","year":"2004","journal-title":"Am Stat"},{"key":"10.1016\/j.vhri.2026.102124_bib30","series-title":"Introductory Econometrics: A Modern Approach","author":"Wooldridge","year":"2020"},{"key":"10.1016\/j.vhri.2026.102124_bib31","series-title":"Sampling of Populations: Methods and Applications","author":"Levy","year":"2013"},{"key":"10.1016\/j.vhri.2026.102124_bib32","series-title":"Estimation and Postestimation Commands. Stata 19 User\u2019s Guide","year":"2025"},{"issue":"6","key":"10.1016\/j.vhri.2026.102124_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4097\/kja.19087","article-title":"Multicollinearity and misleading statistical results","volume":"72","author":"Kim","year":"2019","journal-title":"Korean J Anesthesiol"},{"issue":"6","key":"10.1016\/j.vhri.2026.102124_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40273-018-0623-8","article-title":"Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries","volume":"36","author":"Janssen","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.vhri.2026.102124_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40273-022-01157-3","article-title":"Mapping the patient-reported outcomes measurement information system (PROMIS-29) to EQ-5D-5L","volume":"41","author":"Aghdaee","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.vhri.2026.102124_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jval.2019.09.2755","article-title":"Mapping WOMAC onto the EQ-5D-5L utility index in patients with hip or knee osteoarthritis","volume":"23","author":"Bilbao","year":"2020","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.vhri.2026.102124_bib37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40273-014-0153-y","article-title":"Mapping EQ-5D utility scores from the PedsQL\u2122 generic core scales","volume":"32","author":"Khan","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12955-020-01368-2","article-title":"Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure","volume":"18","author":"Kularatna","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.vhri.2026.102124_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40273-016-0476-y","article-title":"9D utility scores from the PedsQL(TM) 4.0 SF-15","volume":"35","author":"Mpundu-Kaambwa","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.vhri.2026.102124_bib40","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0272989X15577362","article-title":"Predicting the EQ-5D-3L preference index from the SF-12 health survey in a national US sample: a finite mixture approach","volume":"35","author":"Coca Perraillon","year":"2015","journal-title":"Med Decis Mak"},{"issue":"3","key":"10.1016\/j.vhri.2026.102124_bib41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11136-020-02670-8","article-title":"Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer\u2019s disease scale: development and results from a mapping study","volume":"30","author":"Rombach","year":"2021","journal-title":"Qual Life Res"},{"issue":"9","key":"10.1016\/j.vhri.2026.102124_bib42","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jval.2021.03.009","article-title":"Mapping EQ-5D-3L to EQ-5D-5L","volume":"24","author":"van Hout","year":"2021","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.102124_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10198-023-01566-x","article-title":"Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population","volume":"25","author":"Xie","year":"2024","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.vhri.2026.102124_bib44","first-page":"246","article-title":"Regression towards mediocrity in hereditary stature","volume":"15","author":"Galton","year":"1886","journal-title":"J Anthropol Inst Gr Br Irel"},{"key":"10.1016\/j.vhri.2026.102124_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221210992600539X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221210992600539X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:32:03Z","timestamp":1791063123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221210992600539X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":45,"alternative-id":["S221210992600539X"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102124","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping Healthy Days Scores to EQ-5D-5L Utilities: Development and Validation of an Algorithm Using Population Survey Data","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102124"}}